MENU
RVMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Revolution Medicines (RVMD) Earnings Date & Reports

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways... Show more

A.I. Advisor
published Earnings

RVMD is expected to report earnings to fall 3.57% to -108 cents per share on May 12

Revolution Medicines RVMD Stock Earnings Reports
Q1'25
Est.
$-1.08
Q4'24
Missed
by $0.13
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.04
Q1'24
Beat
by $0.05
The last earnings report on February 26 showed earnings per share of -112 cents, missing the estimate of -99 cents. With 1.91M shares outstanding, the current market capitalization sits at 6.11B.
View a ticker or compare two or three
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an oncology company, which focused on developing novel targeted therapies and engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
700 Saginaw Drive
Phone
+1 650 481-6801
Employees
378
Web
https://www.revmed.com